Atlas Trials

Relapsed/Refractory Immune-mediated Kidney Disease

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed/Refractory Immune-mediated Kidney Disease

RecordFirmDate
An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease (NCT07241468)Changhai Hospital2025-11-15

Track Relapsed/Refractory Immune-mediated Kidney Disease automatically

Every clearance here is in the API, with alerts when new ones post.